Hong Kong Electronic Equipment and Components Stock News

SEHK:9908
SEHK:9908Gas Utilities

JiaXing Gas Group (SEHK:9908) Margin Compression In 1H 2025 Tests Bullish Valuation Narrative

JiaXing Gas Group (SEHK:9908) has reported its FY 2025 first half with revenue of C¥1,461.5 million and basic EPS of C¥0.55, setting the tone for how investors will judge the recent pullback in profitability. Over the past three reported halves, revenue has moved from C¥1,516.5 million in 1H 2024 to C¥1,903.8 million in 2H 2024, then to C¥1,461.5 million in 1H 2025. Over the same periods, basic EPS has shifted from C¥0.65 to C¥0.71 and then to C¥0.55, against a trailing twelve month net...
SEHK:2569
SEHK:2569Personal Products

Soft International Group (SEHK:2569) Margin Decline Tests Bullish Revenue Growth Narratives

Soft International Group (SEHK:2569) has just reported its FY 2025 first half results, with revenue of C¥439.3 million, basic EPS of C¥0.034596 and net income excluding extra items of C¥30.5 million. This comes alongside reported 20.3% revenue growth over the past year and a trailing net profit margin of 6.2%. Compared with the last comparable first half, revenue has increased from C¥329.7 million, with basic EPS of C¥0.033017 and net income of C¥24.8 million, to today’s levels. This gives a...
SEHK:588
SEHK:588Real Estate

Beijing North Star (SEHK:588) Multi Billion Yuan TTM Loss Reinforces Bearish Community Narratives

Beijing North Star (SEHK:588) has reported its FY 2025 results with Q4 revenue of C¥1.7b and a net loss of C¥871.6m, translating into EPS of C¥0.25 loss per share. The trailing twelve months show revenue of C¥6.1b and a total loss of C¥3.0b with EPS of C¥0.90 loss per share. Over recent quarters, revenue has ranged from C¥1.2b to C¥1.8b per quarter, while EPS losses have moved between roughly C¥0.09 and C¥0.54 per share. This sets the backdrop for how investors assess the current C¥0.76 share...
SEHK:2171
SEHK:2171Biotechs

Exploring Three High Growth Tech Stocks in Asia

Amidst the backdrop of geopolitical tensions in the Middle East and volatile energy prices, Asian markets have been navigating a complex landscape with varying impacts on different sectors. While large-cap technology stocks face pressure, certain high-growth tech companies in Asia are capturing investor interest due to their innovative capabilities and adaptability in these uncertain times. In such an environment, a good stock is often characterized by its resilience to external shocks,...
SEHK:1234
SEHK:1234Luxury

Exploring 3 Undervalued Asian Small Caps With Insider Buying

Amidst a backdrop of geopolitical tensions and fluctuating energy prices, Asian markets have been navigating a complex landscape that has influenced investor sentiment and market dynamics. With the S&P MidCap 400 and Russell 2000 indexes showing some resilience despite broader market volatility, small-cap stocks in Asia present intriguing opportunities for investors seeking potential value plays. In this context, identifying stocks with strong fundamentals and insider buying can be...
SEHK:9863
SEHK:9863Auto

3 Asian Growth Companies With Insider Ownership Up To 23%

As geopolitical tensions and energy price volatility continue to influence global markets, investors in Asia are navigating a complex landscape marked by both challenges and opportunities. In such an environment, growth companies with significant insider ownership can offer a unique investment angle, as they often reflect strong confidence from those closest to the business.
SEHK:2268
SEHK:2268Life Sciences

Top Asian Stocks Estimated Below Intrinsic Value In March 2026

As geopolitical tensions and energy price volatility continue to influence global markets, Asia's stock indices have experienced mixed outcomes, with investor sentiment swaying in response to these developments. Amidst this uncertainty, identifying stocks that are estimated to be trading below their intrinsic value can offer potential opportunities for investors seeking resilience and growth. In the current market climate, a good stock might be characterized by strong fundamentals and the...
SEHK:3931
SEHK:3931Auto Components

CALB Group (SEHK:3931) Q4 Profit Surge Tests Bullish Earnings Momentum Narrative

CALB Group (SEHK:3931) closed out FY 2025 with Q4 revenue of C¥15.9b and net income of C¥791.0m, while trailing twelve month revenue reached C¥44.4b and net income came in at C¥1.48b. Over the past few quarters the company has seen revenue move from C¥6.6b in Q3 2024 to C¥6.9b in Q1 2025, C¥9.5b in Q2, C¥12.1b in Q3 and C¥15.9b in Q4. Quarterly net income shifted from a loss of C¥68.7m in Q3 2024 to profits of C¥230.2m, C¥235.8m, C¥218.6m and C¥791.0m respectively, alongside trailing EPS of...
SEHK:2667
SEHK:2667Healthcare

Three Emerging Asian Stocks With Promising Potential

As global markets navigate the complexities of geopolitical tensions and energy price volatility, Asian markets are also feeling the ripple effects, with investor sentiment being shaped by these macroeconomic shifts. In this environment, identifying emerging stocks that show resilience and adaptability can be key to uncovering potential opportunities in Asia's dynamic economic landscape.
SEHK:2225
SEHK:2225Professional Services

Asian Penny Stocks With Market Caps Under US$2B To Consider

Amidst the backdrop of geopolitical tensions and fluctuating energy prices, Asian markets are navigating a complex landscape that has investors on edge. While large-cap stocks often dominate headlines, penny stocks—despite their old-fashioned name—remain an intriguing option for those seeking to explore smaller or newer companies with potential upside. By focusing on firms with strong financials and growth prospects, investors can uncover hidden value in these lesser-known equities.
SEHK:9911
SEHK:9911Interactive Media and Services

Newborn Town (SEHK:9911) Valuation Check After Strong 2025 Results And New HK$300 Million Buyback

Newborn Town (SEHK:9911) has drawn renewed attention to its stock after reporting its 2025 annual results and unveiling a new share repurchase program of up to HK$300 million, funded from internal resources. See our latest analysis for Newborn Town. Newborn Town’s share price has softened in recent months, with a 30 day share price return of 14.24% and a year to date share price return decline of 31.51%. At the same time, the 3 year total shareholder return of about 7x and 1 year total...
SEHK:2190
SEHK:2190Medical Equipment

A Look At Zylox-Tonbridge Medical Technology (SEHK:2190) Valuation After 2025 Earnings Growth And Proposed Final Dividend

Zylox-Tonbridge Medical Technology (SEHK:2190) has drawn attention after reporting full year 2025 earnings, with sales of CNY 1,057.49 million and net income of CNY 244.37 million, alongside a proposed ordinary final dividend. See our latest analysis for Zylox-Tonbridge Medical Technology. The latest earnings and dividend proposal sit alongside share price momentum that has been building over the past month, with a 10.09% 1 month share price return and a 49.00% 1 year total shareholder...
SEHK:3808
SEHK:3808Machinery

Sinotruk (Hong Kong) (SEHK:3808) Earnings Growth Outpaces Revenue And Tests Cautious Narratives

Sinotruk (Hong Kong) (SEHK:3808) has put up another set of solid numbers for FY 2025, with first half revenue at about C¥50.9b and basic EPS of C¥1.25, backed by trailing twelve month revenue of roughly C¥109.5b and EPS of C¥2.57. Over the past three reported halves, revenue has moved from C¥48.8b in 1H 2024 to C¥46.2b in 2H 2024 and then to C¥50.9b in 1H 2025. Basic EPS tracked at C¥1.20, C¥0.94 and C¥1.25 respectively, supported by trailing twelve month EPS that stepped up from C¥2.14 to...
SEHK:9969
SEHK:9969Biotechs

A Look At InnoCare Pharma (SEHK:9969) Valuation After Recent Share Price Momentum

Recent share performance and business snapshot InnoCare Pharma (SEHK:9969) has drawn investor attention after a 5.7% one day gain, adding to a one month return of 12.8% and a past 3 months return recorded as 0%. The Hong Kong listed biopharmaceutical group focuses on cancer and autoimmune disease treatments in China, with revenue of CN¥2,374.906 million and net income of CN¥642.467 million reported in its latest figures. See our latest analysis for InnoCare Pharma. At the current share price...
SEHK:3393
SEHK:3393Electronic

Assessing Wasion Holdings (SEHK:3393) Valuation After Strong Earnings And Major Brazilian Contract Win

Earnings and Contract Win Set the Scene for Wasion Holdings Wasion Holdings (SEHK:3393) has drawn fresh attention after reporting full year 2025 earnings, alongside securing an exclusive recloser supply contract with Brazilian power group Companhia Energética de Minas Gerais S.A. See our latest analysis for Wasion Holdings. The recent earnings release and Brazilian contract news arrive after a strong run in the shares, with a 90 day share price return of 75.81% and a 1 year total shareholder...
SEHK:883
SEHK:883Oil and Gas

Is It Too Late To Consider CNOOC (SEHK:883) After A 69% One-Year Surge?

Wondering whether CNOOC’s current share price still offers value after a strong run, or if you may be turning up late to the story. CNOOC shares last closed at HK$29.06, with returns of 17.8% over 30 days, 32.9% year to date, and 69.2% over 1 year, while the 7 day return shows a 4.3% pullback that may have changed how investors view the near term risk and reward. Recent news flow around CNOOC has focused on its role in global energy markets and investor attention on large oil and gas...
SEHK:2282
SEHK:2282Hospitality

Assessing MGM China Holdings (SEHK:2282) Valuation After Earnings Growth And Dividend Announcement

The latest earnings release for MGM China Holdings (SEHK:2282), combined with a proposed final ordinary dividend of HK$0.353 per share, has drawn fresh attention to how the stock reflects these updated fundamentals. See our latest analysis for MGM China Holdings. Despite a 2.27% 1 day share price return to HK$11.24, the 30 day and 90 day share price returns of 11.01% and 27.86% declines suggest momentum has recently faded, even as the 1 year and 3 year total shareholder returns of 8.45% and...
SEHK:268
SEHK:268Software

A Look At Kingdee (SEHK:268) Valuation After Its Return To Full Year Profitability

Why Kingdee’s latest results are drawing fresh attention Kingdee International Software Group (SEHK:268) is back in focus after its full year 2025 results showed CNY 7,006.04 million in sales and net income of CNY 92.91 million, compared with a loss a year earlier. See our latest analysis for Kingdee International Software Group. At a share price of HK$8.83, Kingdee’s 1 day share price return of 0.91% sits against weaker recent momentum. This includes a 30 day share price return of 10.63% and...
SEHK:1963
SEHK:1963Banks

Assessing Bank Of Chongqing (SEHK:1963) Valuation After Strong Full Year Earnings Results

Earnings trigger and why it matters now Bank of Chongqing (SEHK:1963) has drawn fresh attention after reporting its full year 2025 results, with net interest income at CN¥12,459.41 million and net income at CN¥5,654.22 million, both higher than the previous year. See our latest analysis for Bank of Chongqing. At a share price of HK$7.97, Bank of Chongqing has seen a 3.64% 1 month share price return, while its 1 year total shareholder return of 26.65% and 3 year total shareholder return of...
SEHK:1361
SEHK:1361Luxury

Assessing 361 Degrees International (SEHK:1361) Valuation After Strong 2025 Results And Higher Final Dividend Recommendation

361 Degrees International (SEHK:1361) has drawn renewed attention to its stock after reporting full year 2025 results and recommending a higher final dividend, aligning earnings and shareholder payouts more closely. See our latest analysis for 361 Degrees International. At a share price of HK$6.0, the stock has added momentum recently, with a 7 day share price return of 11.94% and a 1 year total shareholder return of 41.19%. This suggests growing optimism after the earnings and dividend...
SEHK:6963
SEHK:6963Insurance

Did Sunshine Insurance Group's (SEHK:6963) Higher EPS and Dividend Plan Just Recast Its Investment Narrative?

Sunshine Insurance Group Company Limited reported past full-year 2025 results, with net income of CNY 6,307 million and basic earnings per share of CNY 0.55, and proposed a final cash dividend of CNY 0.19 per ordinary share payable on 28 July 2026. The combination of higher earnings per share and a cash dividend proposal highlights how Sunshine Insurance Group is balancing profitability with direct capital returns to shareholders. Against this backdrop, we will examine how the company’s...
SEHK:939
SEHK:939Banks

China Construction Bank (SEHK:939) Margins Hold Firm As Net Interest Margin Dip Tests Bullish Narratives

China Construction Bank (SEHK:939) has laid out its FY 2025 scorecard with fourth quarter revenue of CNY 169.0b and basic EPS of CNY 0.30, alongside trailing twelve month revenue of CNY 607.6b and EPS of CNY 1.30. Over recent periods, revenue has ranged from CNY 165.1b in Q4 2024 to CNY 169.0b in Q4 2025, while quarterly EPS has held around CNY 0.30 to CNY 0.35. This presents a picture of steady top line scale supported by high margins, framing the latest results as a balance of income...
SEHK:2162
SEHK:2162Biotechs

A Look At Keymed Biosciences (SEHK:2162) Valuation After Annual Results And Commercialization Progress

Why Keymed Biosciences just drew fresh attention Keymed Biosciences (SEHK:2162) has come into focus after releasing its 2025 annual results, with higher reported sales, a wider net loss in absolute terms, and a slightly smaller loss per share from continuing operations. See our latest analysis for Keymed Biosciences. The latest earnings release and wider shift toward commercialization appear to be feeding into stronger momentum, with a 1-day share price return of 5.03% and a 1-year total...
SEHK:1645
SEHK:1645Machinery

Haina Intelligent Equipment International Holdings SEHK 1645 Returns To Profit In First Half Challenging Bearish Narratives

Haina Intelligent Equipment International Holdings (SEHK:1645) has reported FY 2025 first half revenue of C¥224.2 million and basic EPS of C¥0.0156, while the trailing twelve months show revenue of C¥411.4 million and a net loss of C¥17.7 million with basic EPS of C¥0.0314. Over recent periods, the company has seen revenue move from C¥182.4 million and basic EPS of C¥0.0206 in the first half of FY 2024 to C¥187.3 million with basic EPS of C¥0.0470 in the second half, before reaching the...